Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products in the People's Republic of China. Its Pharmaceutical Distribution segment offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. This segment distributes medicines, medical devices, and pharmaceutical products to hospitals, other distributors, retail drug stores, and clinics. The company's Retail Pharmacy segment operates and franchises a network of retail drug stores. As of December 31, 2018, this segment had 5,183 retail pharmacies. Its Medical Devices segment distributes medical devices. Its Other Business segment engages in the production, sale, and financial leasing of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consultation, market information consultation and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China.
Industry, Sector and Symbol
Industry Medical Distributors
Sub-IndustryN/A
SectorDistribution Services
CIKN/A
Phone86 21 2305 2666
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees69,722
Next Earnings DateN/A
OptionableNot Optionable
Sinopharm (OTCMKTS:SHTDF) Frequently Asked Questions
What is Sinopharm's stock symbol?
Sinopharm trades on the OTCMKTS under the ticker symbol "SHTDF."
Has Sinopharm been receiving favorable news coverage?
Media coverage about SHTDF stock has been trending very negative on Wednesday, according to InfoTrie. The research firm ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Sinopharm earned a media sentiment score of -3.3 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 2.0 out of 10, indicating that recent media coverage is very unlikely to have an impact on the stock's share price in the near future. View News Stories for Sinopharm.
Who are some of Sinopharm's key competitors?
Who are Sinopharm's key executives?
Sinopharm's management team includes the folowing people:
- Mr. Zhiming Li, Chairman (Age 56)
- Mr. Yong Liu, Pres & Exec. Director (Age 50)
- Mr. Yijian Wu, Company Sec. (Age 49)
- Mr. Wanyong Lian, VP (Age 48)
- Mr. Dongjiu Li, VP (Age 54)
How do I buy shares of Sinopharm?
Shares of SHTDF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Sinopharm's stock price today?
One share of SHTDF stock can currently be purchased for approximately $3.55.
What is Sinopharm's official website?
How can I contact Sinopharm?
The company can be reached via phone at 86 21 2305 2666.
MarketBeat Community Rating for Sinopharm (OTCMKTS SHTDF)
MarketBeat's community ratings are surveys of what our community members think about Sinopharm and other stocks. Vote "Outperform" if you believe SHTDF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SHTDF will underperform the S&P 500 over the long term. You may vote once every thirty days.
